Author:
Thiurunavukkarau Rajasekar,Shanmugam Sabarika,Subramanian Kumaran,Pandi Priyadarshini,Muralitharan Gangatharan,Arokiarajan Maryshamya,Kasinathan Karthika,Sivaraj Anbarasu,Kalyanasundaram Revathy,AlOmar Suliman Yousef,Shanmugam Velmurugan
Abstract
AbstractWorld-wide antimicrobial resistant is biggest threat in global health. It requires the urgent need of multisectoral action for the scientific community to achieve the sustainable development Goals. Due to their antimicrobial properties, silver nanoparticles are potential activates to pathogens, which explains their potential for multiple applications in various fields. In the present studies, we evaluate the antimicrobial properties of a Sargassum polycystum algal extract, an unrivaled green synthetic method for producing -defined shaped seaweed silver nanoparticles. To confirm their structure and size, some characterization techniques are used, such as Absorption spectrophotometer (UV–VIS), Fourier transforms infrared spectroscopy (FTIR), Scanning electron Microscope (SEM), Transmission electron microscopy (TEM) and X-Ray diffraction (XRD). Evaluate the antibacterial and anti-mycobacterial activity using silver nanoparticles. The toxicity study of this silver nanoparticle has been done with the help of zebrafish larva. The biological nanoparticle having good antimicrobial activity against Staphylococcus aureus, Micrococcus luteus, Pseudomonas fluorescens and Candida albicans and also it shows potent activity against MTB H37Rv, SHRE sensitive MTB Rifampicin resistant MTB around 98%. Seaweed nanoparticles had lower toxicity for the survival of the fish larvae. In comparison, other dosages will arrest the cell cycle and leads to death. The present finding revealed that these seaweeds nanoparticles have potential anti-mycobacterial activity against pathogens at low concentrations. This makes them a potent source of antibacterial and anti-TB agents
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. World Health Organization: Global tuberculosis control-surveillance, planning, finances (2018).
2. Comas, I. & Gagneux, S. The past and future of tuberculosis research. PLoS Pathog. 5(10), e1000600 (2009).
3. World Health Organization: World Health Organization Global Tuberculosis Report (2017).
4. Barry R. Bloom (Ed): Tuberculosis: pathogenesis, protection, and control. ASM press (1994).
5. Bekele, A. Z., Gokulan, K., Williams, K. M. & Khare, S. Dose and size-dependent antiviral efects of silver nanoparticles on Feline calicivirus, a human norovirus surrogate. Foodborne Pathog. Dis. 13, 239–244 (2016).
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献